Literature DB >> 25529289

Age at HPV vaccine initiation and completion among US adolescent girls: trend from 2008 to 2012.

Mahbubur Rahman1, Christine J McGrath2, Jacqueline M Hirth2, Abbey B Berenson2.   

Abstract

OBJECTIVE: To examine the trend of provider-verified HPV vaccine initiation (≥1 dose) and completion (≥3 doses) among adolescent girls at the Advisory Committee on Immunization Practices (ACIP) recommended age (11-12 years).
METHODS: We analyzed National Immunization Survey of Teens 2008-2012 data and examined the trend of provider-verified HPV vaccine initiation and completion among <13 year old girls.
RESULTS: Data on age at HPV vaccine initiation and completion were available for 24,466 and 15,972 girls, respectively. The weighted proportion of girls who initiated the vaccine at <13 years of age was 14.1%, 24.1%, 35.9%, 47.7% and 55.9% in 2008, 2009, 2010, 2011 and 2012, respectively (p for trend <.001). The similar trend was also observed for mean age at HPV vaccine initiation and completion (p<.001).
CONCLUSIONS: Additional efforts are needed to increase HPV vaccine uptake among adolescent girls as only half of them receive this vaccine at ACIP recommended age.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adolescent girls; Age at vaccine completion; Age at vaccine initiation; HPV vaccine; Human papillomavirus (HPV)

Mesh:

Substances:

Year:  2014        PMID: 25529289      PMCID: PMC4304974          DOI: 10.1016/j.vaccine.2014.12.021

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2010-05-28       Impact factor: 17.586

2.  Mothers' intention for their daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses.

Authors:  Jessica A Kahn; Lili Ding; Bin Huang; Gregory D Zimet; Susan L Rosenthal; A Lindsay Frazier
Journal:  Pediatrics       Date:  2009-06       Impact factor: 7.124

3.  Uptake of human papillomavirus vaccine among adolescent males and females: Immunization Information System sentinel sites, 2009-2012.

Authors:  Karen A Cullen; Shannon Stokley; Lauri E Markowitz
Journal:  Acad Pediatr       Date:  2014-06-20       Impact factor: 3.107

4.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

5.  Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure.

Authors:  Matthew F Daley; Lori A Crane; Lauri E Markowitz; Sandra R Black; Brenda L Beaty; Jennifer Barrow; Christine Babbel; Sami L Gottlieb; Nicole Liddon; Shannon Stokley; L Miriam Dickinson; Allison Kempe
Journal:  Pediatrics       Date:  2010-08-02       Impact factor: 7.124

6.  Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited.

Authors:  Susan T Vadaparampil; Jessica A Kahn; Daniel Salmon; Ji-Hyun Lee; Gwendolyn P Quinn; Richard Roetzheim; Karen Bruder; Teri L Malo; Tina Proveaux; Xiuhua Zhao; Neal Halsey; Anna R Giuliano
Journal:  Vaccine       Date:  2011-09-14       Impact factor: 3.641

7.  Prevalence of HPV infection among females in the United States.

Authors:  Eileen F Dunne; Elizabeth R Unger; Maya Sternberg; Geraldine McQuillan; David C Swan; Sonya S Patel; Lauri E Markowitz
Journal:  JAMA       Date:  2007-02-28       Impact factor: 56.272

8.  Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system.

Authors:  Amanda Dempsey; Lisa Cohn; Vanessa Dalton; Mack Ruffin
Journal:  Vaccine       Date:  2009-11-17       Impact factor: 3.641

Review 9.  Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia.

Authors:  F Xavier Bosch; Ann N Burchell; Mark Schiffman; Anna R Giuliano; Silvia de Sanjose; Laia Bruni; Guillermo Tortolero-Luna; Susanne Kruger Kjaer; Nubia Muñoz
Journal:  Vaccine       Date:  2008-08-19       Impact factor: 3.641

10.  Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine.

Authors:  Suzanne M Garland; Marc Steben; Heather L Sings; Margaret James; Shuang Lu; Radha Railkar; Eliav Barr; Richard M Haupt; Elmar A Joura
Journal:  J Infect Dis       Date:  2009-03-15       Impact factor: 5.226

  10 in total
  17 in total

Review 1.  Pharmacologic management of advanced cervical cancer: antiangiogenesis therapy and immunotherapeutic considerations.

Authors:  Teresa C Longoria; Krishnansu S Tewari
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

2.  Correlates of Human Papillomavirus Vaccine Completion Among Adolescent Girl Initiators.

Authors:  Mahbubur Rahman; Tabassum H Laz; Christine J McGrath; Abbey B Berenson
Journal:  Clin Pediatr (Phila)       Date:  2015-04-06       Impact factor: 1.168

3.  Risk of Delayed Human Papillomavirus Vaccination in Inner-City Adolescent Women.

Authors:  Nicolas F Schlecht; Angela Diaz; Viswanathan Shankar; Arnold H Szporn; Maoxin Wu; Anne Nucci-Sack; Ken Peake; Howard D Strickler; Robert D Burk
Journal:  J Infect Dis       Date:  2016-10-12       Impact factor: 5.226

4.  Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system.

Authors:  Chun Chao; Michael J Silverberg; Tracy A Becerra; Douglas A Corley; Christopher D Jensen; Qiaoling Chen; Virginia P Quinn
Journal:  Am J Obstet Gynecol       Date:  2016-10-14       Impact factor: 8.661

5.  Recommend, but also Discuss: Different Patterns of Physician-Perceived Barriers to Discussing HPV Vaccination and Their Association with Vaccine Administration in 11-12 Year-Old Girls.

Authors:  Andrzej Kulczycki; Haiyan Qu; Richard Shewchuk
Journal:  Matern Child Health J       Date:  2016-12

6.  Adherence to ACIP Recommendation for Human Papillomavirus Vaccine Among US Adolescent Girls.

Authors:  Mahbubur Rahman; Jacqueline M Hirth; Abbey B Berenson
Journal:  J Community Health       Date:  2017-04

7.  Association of physicians perceived barriers with human papillomavirus vaccination initiation.

Authors:  Albert J Farias; Lara S Savas; Maria E Fernandez; Sharon P Coan; Ross Shegog; C Mary Healy; Erica Lipizzi; Sally W Vernon
Journal:  Prev Med       Date:  2017-08-20       Impact factor: 4.018

8.  Effect of number of human papillomavirus vaccine doses on guideline adherent cervical cytology screening among 19-26year old females.

Authors:  Jacqueline M Hirth; Yu-Li Lin; Yong-Fang Kuo; Abbey B Berenson
Journal:  Prev Med       Date:  2016-04-13       Impact factor: 4.018

9.  Physicians', Nurses', and Medical Assistants' Perceptions of the Human Papillomavirus Vaccine in a Large Integrated Health Care System.

Authors:  Jordan Mills; Patrick Van Winkle; Macy Shen; Christina Hong; Sharon Hudson
Journal:  Perm J       Date:  2016-09-13

10.  Providers' beliefs about the effectiveness of the HPV vaccine in preventing cancer and their recommended age groups for vaccination: Findings from a provider survey, 2012.

Authors:  Z Berkowitz; M Malone; J Rodriguez; M Saraiya
Journal:  Prev Med       Date:  2015-10-24       Impact factor: 4.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.